Abstract:Abstract Background Secondary hemophagocytic syndrome (SHS) may develop as a result of excessive immune activation, with proliferation of T cells and macrophages. It is often fatal and remains ill-recognized in children, leading to false or delayed diagnosis and suboptimal management. This condition has been described more often in association with virus, but it can be secondary to bacteria, fungi, and parasites. Methods Retrospective, descriptive, and observational study. We systematically reviewed the clinical files of patients diagnosed with SHS at the Instituto Nacional de Pediatría between January 1995 and December 2018; age, gender, clinical features, laboratory results, management, and final outcome were registered. Results 49 cases of SHS were diagnosed, 26 (53%) were male, mean age at diagnosis was 67.5 months (newborn–15.5 years), 47 (96%) presented with fever, 46 (94%) hepatomegaly, 37 (76%) splenomegaly, 28 (57%) lymphadenopathy, 18 (37%) jaundice, and 4 (8%) bleeding. The most common laboratory findings were anemia in 29 (59%) patients, thrombocytopenia in 39 (80%), hypertriglyceridemia in 39 (80%), with isolation of Epstein Barr Virus in 18 (35%), followed by Cytomegalovirus in 2 (4%), Escherichia coli in 2 (4%), Salmonella enterica in 2 (4%), and Leptospira, Brucella abortus, Shigella sonnei, Enterococcus faecium, Enterovirus and congenital Rubella in 1 case each (2%). Intravenous Gamma-globulin therapy was administered to 38 (78%) patients, antimicrobials to 26 (53%), systemic steroids to 46 (94%) and VP16 to 32 (65%). 22 (45%) had full recovery, 6 (12%) patients presented with a recurrent episode of SHS, and 21 (43%) died. Conclusion Due to the rarity of this syndrome, variable clinical presentation, and lack of specificity of the clinical and laboratory findings, the diagnosis of SHS is often delayed. EBV remains an important etiologic agent of this syndrome, identified in 35% of our cases. The mortality rate around the world is reported approximately around 45%, confirmed in our study in 43% of the cases, remarking the importance of prompt diagnosis and treatment to increase the survival in our population. Disclosures All authors: No reported disclosures.

Survival of Hemophagocytic Syndrome Secondary to Fungal and Bacterial Infection in a Pediatric Patient with HIV: A Case Report

Hemophagocytic Lymphohistiocytosis Secondary to Disseminated Histoplasmosis in HIV Seronegative Patients: A Case Report and Review of the Literature.

Successful management of haemophagocytic lymphohistiocytosis in an adolescent with newly diagnosed HIV/AIDS and histoplasmosis

Haemophagocytic lymphohistiocytosis (HLH) secondary to disseminated histoplasmosis infection in a patient with HIV

Secondary hemophagocytic syndrome in an acquired immunodeficiency syndrome and Alpha-thalassemia patient infected with Talaromyces marneffei: A case report and literature review

Hemophagocytic Lymphohistiocytosis Secondary to Chronic Lymphocytic Leukaemia and Multiple Infections Manifested with Quotidian Pyrexia: A Case Report

Disseminated Histoplasmosis and Secondary Hemophagocytic Syndrome in a Non-HIV Patient

1531. A Twenty 3-Year Retrospective Study of Secondary Hemophagocytic Syndrome in a Pediatric Third-Level Referral Center in Mexico City

Clinical and Biochemical Characteristics of Hemophagocytic Lymphohistiocytosis in People Living With HIV and Disseminated Histoplasmosis at a Tertiary Hospital in Mexico

Transfusion-Associated HIV Infection in Pediatric Leukemia Patients (two Case Reports).

Acute human immunodeficiency virus infection associated hemophagocytic lymphohistiocytosis

Hemophagocytic lymphohistiocytosis secondary to Candida albicans and reactivated EBV infections: A case report and review of the literature

Clinical Presentation and Outcome of Pediatric Patients with Hemophagocytic Lymphohistiocytosis in China: A Retrospective Multicenter Study

Hemophagocytic Lymphohistiocytosis Secondary to Acute Human Immunodeficiency Virus and COVID-19

Secondary hemophagocytic lymphohistiocytosis in pediatric patients: a single center experience and factors that influenced patient prognosis

From diagnosis to treatment: a successful case of haemophagocytic lymphohistiocytosis of presumed bacterial aetiology in an adult.

Overcoming Diagnostic Challenges: A Rare Presentation of Primary Hemophagocytic Lymphohistiocytosis (HLH) in a Young Female and the Importance of Timely Recognition

Hemophagocytic lymphohistiocytosis secondary to AIDS-related histoplasmosis and visceral leishmaniasis

Malignancy-Associated Secondary Hemophagocytic Lymphohistiocytosis Mimicking an Infection: A Case Report and Review of the Literature

Secondary hemophagocytic lymphohistiocytosis triggered by Staphylococcus aureus bacteremia: A case report and systemic review

Hemophagocytic Lymphohistiocytosis Associated With Parvovirus B19 in a Patient With Acquired Immunodeficiency Syndrome